RGT fundamentals
An in-depth look to ARGENT BIOPHARMA LIMITED ORD NPV (DI) operating, investing, and financing activities
RGT free cash flow for H1 24 is -4.24 M GBP. For 2023, RGT free cash flow was -6.39 M GBP and operating cash flow was -6.29 M GBP.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: GBP
TTM